-
161por Kalra, Maitri, Henry, Elizabeth, McCann, Kelly, Karuturi, Meghan S, Bustamante Alvarez, Jean G, Parkes, Amanda, Wesolowski, Robert, Wei, Mei, Mougalian, Sarah S, Durm, Gregory, Qin, Angel, Schonewolf, Caitlin, Trivedi, Meghna, Armaghani, Avan J, Wilson, Frederick H, Iams, Wade T, Turk, Anita A, Vikas, Praveen, Cecchini, Michael, Lubner, Sam, Pathak, Priyadarshini, Spencer, Kristen, Koshkin, Vadim S, Labriola, Matthew K, Marshall, Catherine H, Beckermann, Katy E, Sharifi, Marina N, Bejjani, Anthony C, Hotchandani, Varsha, Housri, Samir, Housri, Nadine“…OBJECTIVE: Using an oncologist-only question and answer (Q&A) website, we sought to document expert insights from TBs at National Cancer Institute–designated Comprehensive Cancer Centers (NCI-CCCs) to provide educational benefits to the oncology community. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
162por Zahir, Hamim, Greenberg, Jonathan, Hsu, Ching, Marbury, Thomas C., Lasseter, Kenneth C., Xu, Li‐An, Tap, William D., Healey, John H., Stacchiotti, Silvia, LaCreta, Frank“…The objective of the two phase 1, open‐label studies was to determine the pharmacokinetics of pexidartinib after a single 200‐mg dose in subjects with mild and moderate HI, based on Child–Pugh classification (PL3397‐A‐U123: 8 mild HI and 8 moderate HI vs 16 matched healthy controls) and National Cancer Institute Organ Dysfunction Working Group (NCI‐ODWG) criteria (PL3397‐A‐U129: 8 moderate HI versus 8 matched healthy controls [NCT04223635]). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
163por Olaku, Oluwadamilola, Conley, Barbara A., Ivy, S. Percy, McShane, Lisa M., Staudt, Louis M., King, Sophie M., Sansevere, Megan, Kim, Benjamin, White, Jeffrey D.“…INTRODUCTION: The Exceptional Responders Initiative (ERI) at the National Cancer Institute attempts to correlate unusually good outcomes in patients with cancer with genetic targets in tumors and the therapies the patients received. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
164por Edirisinghe, Sajith Tilal, Devmini, Thisara, Pathmaperuma, Shanaka, Weerasekera, Manjula, De Silva, Kanishka, Liyanage, Indunil, Niluka, Malith, Madushika, Kasuni, Deegodagamage, Sandeepani, Wijesundara, Chanuka, Rich, Alison, De Silva, Harsha, Hussaini, Haizal, De Silva, Dulmini Kavindya, Yasawardene, Surangi“…OBJECTIVES: This study aimed to determine the use of alcohol, its duration and consuming pattern in relation to the risk of developing OSCC in patients attending the National Cancer Institute of Sri Lanka. METHODS: A case-control study was carried out on 105 patients with a histologically confirmed primary OSCC and 210 age-sex matched controls. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
165“…The carcinogenicity database used for this paper originated in the late 1960s by the National Cancer Institute (NCI) and since 1978 has been continued and made more comprehensive by the National Toxicology Program (NTP). …”
Enlace del recurso
Enlace del recurso
Texto -
166por Evans, W. K., Eisenhauer, E., Hughes, P., Maroun, J. A., Ayoub, J., Shepherd, F. A., Feld, R.Enlace del recurso
Publicado 1988
Enlace del recurso
Texto -
167por Fan, Cong, Huang, Yan-Xin, Bao, Yong-Li, Sun, Lu-Guo, Wu, Yin, Yu, Chun-Lei, Zhang, Yu, Song, Zhen-Bo, Zheng, Li-Hua, Sun, Ying, Wang, Guan-Nan, Li, Yu-Xin“…Using these workflows, 17 of 139,735 compounds in the NCI (National Cancer Institute) database were identified as potential specific inhibitors of IGF1R. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
168por Checkoway, Harvey, Dell, Linda D., Boffetta, Paolo, Gallagher, Alexa E., Crawford, Lori, Lees, Peter SJ., Mundt, Kenneth A.Enlace del recurso
Publicado 2015
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
169por Botos, Jeannine“…BACKGROUND: Associations were examined between author-reported uses of reporting guidelines to prepare JNCI: Journal of the National Cancer Institute (JNCI) submissions, editorial decisions, and reviewer ratings for adherence to reporting guidelines and clarity of presentation. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
170por Mohile, Supriya G., Epstein, Ronald M., Hurria, Arti, Heckler, Charles E., Canin, Beverly, Culakova, Eva, Duberstein, Paul, Gilmore, Nikesha, Xu, Huiwen, Plumb, Sandy, Wells, Megan, Lowenstein, Lisa M., Flannery, Marie A., Janelsins, Michelle, Magnuson, Allison, Loh, Kah Poh, Kleckner, Amber S., Mustian, Karen M., Hopkins, Judith O., Liu, Jane Jijun, Geer, Jodi, Gorawara-Bhat, Rita, Morrow, Gary R., Dale, William“…DESIGN, SETTING, AND PARTICIPANTS: This cluster-randomized clinical trial enrolled 541 participants from 31 community oncology practices within the University of Rochester National Cancer Institute Community Oncology Research Program from October 29, 2014, to April 28, 2017. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
171“…METHODS: We combined data from the 2017 and 2018 National Cancer Institute Health Information National Trends Survey (N=6789) to characterize respondents according to 5 mutually exclusive reported patterns of mHealth use for health and behavioral tracking: (1) mHealth nonowners and nonusers report not owning or using devices to track health, behaviors, or goals; (2) supertrackers track health or behaviors and goals using a smartphone or tablet plus other devices (eg, Fitbit); (3) app trackers use only a smartphone or tablet; (4) device trackers use only nonsmartphone or nontablet devices and do not track goals; and (5) nontrackers report having smartphone or tablet health apps but do not track health, behaviors, or goals. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
172“…In 1971, Congress passed the National Cancer Act, landmark legislation that reorganized the National Institutes of Health's National Cancer Institute (NCI). The Act included a new focus on cancer control, including the requirement that the NCI award research grants and contracts, in collaboration with other public agencies and private industry, to conduct cancer control activities related to the diagnosis, prevention, and treatment of cancer. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
173“…BACKGROUND: The aim of this study was to translate and linguistically validate the U.S. National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE™) into Simplified Chinese for use in Singapore. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
174por Aschbrenner, Kelly A., Oh, April Y., Tabak, Rachel G., Hannon, Peggy A., Angier, Heather E., Moore, W. Todd, Likumahuwa-Ackman, Sonja, Carroll, Jennifer K., Baumann, Ana A., Beidas, Rinad S., Mazzucca-Ragan, Stephanie, Waters, Erika A., Sadasivam, Rajani S., Shelton, Rachel C.“…BACKGROUND: A Health Equity Task Force (HETF) of members from seven Centers funded by the National Cancer Institute’s (NCI) Implementation Science in Cancer Control Centers (ISC(3)) network sought to identify case examples of how Centers were applying a focus on health equity in implementation science to inform future research and capacity-building efforts. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
175por Cox, David G, Blanché, Hélène, Pearce, Celeste L, Calle, Eugenia E, Colditz, Graham A, Pike, Malcolm C, Albanes, Demetrius, Allen, Naomi E, Amiano, Pilar, Berglund, Goran, Boeing, Heiner, Buring, Julie, Burtt, Noel, Canzian, Federico, Chanock, Stephen, Clavel-Chapelon, Françoise, Feigelson, Heather Spencer, Freedman, Matthew, Haiman, Christopher A, Hankinson, Susan E, Henderson, Brian E, Hoover, Robert, Hunter, David J, Kaaks, Rudolf, Kolonel, Laurence, Kraft, Peter, LeMarchand, Loic, Lund, Eiliv, Palli, Domenico, Peeters, Petra HM, Riboli, Elio, Stram, Daniel O, Thun, Michael, Tjonneland, Anne, Trichopoulos, Dimitrios, Yeager, Meredith“…Here, we report on the results of a large and comprehensive study of the association between genetic variation in the AR gene and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). …”
Publicado 2006
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
176por Bauml, Joshua, Xie, Sharon X, Penn, Courtney, Desai, Krupali, Dong, Kimberly W, Bruner, Deborah Watkins, Vapiwala, Neha, Mao, Jun James“…This study seeks to evaluate the outcome and patient receptiveness of a brief counseling program based on National Cancer Institute (NCI) PDQ® information to manage CRF when integrated into Radiation Therapy (RT). …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
177por Garcia, Denise, Spruill, Laura S., Irshad, Abid, Wood, Jennifer, Kepecs, Denise, Klauber-DeMore, Nancy“…BACKGROUND: This study aimed to investigate the changes in diagnosis after a second opinion for breast cancer patients from a multi-disciplinary tumor board (MTB) review at an National Cancer Institute (NCI)-designated cancer center. METHODS: A retrospective study analyzed patients with a breast cancer diagnosed at an outside institution who presented for a second opinion from August 2015 to March 2016 at the Medical University of South Carolina (MUSC). …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
178“…METHODS: Enterobacteriaceae isolates resistant to carbapenems were collected from clinical samples submitted for routine testing to the microbiology laboratory of National Cancer Institute. Species identification was done using conventional biochemicals and CLSI disc diffusion method was used for ABST of CRE isolates. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
179por Meza, Rafael, Jeon, Jihyoun, Jimenez-Mendoza, Evelyn, Mok, Yoonseo, Cao, Pianpian, Foley, Kristie L., Chiles, Caroline, Ostroff, Jamie S., Cinciripini, Paul M., Minnix, Jennifer, Rigotti, Nancy A., Haas, Jennifer S., Taylor, Kathryn, Williams, Randi M., Toll, Benjamin A., Joseph, Anne M.“…INTRODUCTION: The National Cancer Institute Smoking Cessation at Lung Examination (SCALE) Collaboration includes eight clinical trials testing smoking cessation interventions delivered with lung cancer screening (LCS). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
180“…This study was carried out to evaluate the surgical outcomes, five-year survival, and disease-free survival following radical hysterectomies at the National Cancer Institute, Sri Lanka, which performs the largest number of radical hysterectomies annually in the country. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto